Manulife (Manufacturers Life Insurance)’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Buy |
78,515
+18,280
| +30% | +$256K | ﹤0.01% | 1777 |
|
|
2025
Q1 | $812K | Buy |
60,235
+10,515
| +21% | +$142K | ﹤0.01% | 1903 |
|
|
2024
Q4 | $953K | Buy |
49,720
+24,988
| +101% | +$479K | ﹤0.01% | 1932 |
|
|
2024
Q3 | $563K | Sell |
24,732
-6,955
| -22% | -$158K | ﹤0.01% | 2221 |
|
|
2024
Q2 | $412K | Buy |
31,687
+7,450
| +31% | +$96.9K | ﹤0.01% | 2293 |
|
|
2024
Q1 | $424K | Buy |
24,237
+8,182
| +51% | +$143K | ﹤0.01% | 2263 |
|
|
2023
Q4 | $350K | Sell |
16,055
-356
| -2% | -$7.75K | ﹤0.01% | 2334 |
|
|
2023
Q3 | $252K | Sell |
16,411
-577
| -3% | -$8.85K | ﹤0.01% | 2456 |
|
|
2023
Q2 | $404K | Buy |
16,988
+1,951
| +13% | +$46.4K | ﹤0.01% | 2176 |
|
|
2023
Q1 | $383K | Buy |
15,037
+609
| +4% | +$15.5K | ﹤0.01% | 2169 |
|
|
2022
Q4 | $421K | Buy |
14,428
+3,789
| +36% | +$111K | ﹤0.01% | 2098 |
|
|
2022
Q3 | $218K | Sell |
10,639
-89
| -0.8% | -$1.83K | ﹤0.01% | 2530 |
|
|
2022
Q2 | $124K | Buy |
+10,728
| New | +$124K | ﹤0.01% | 2837 |
|
|
2018
Q3 | – | Sell |
-1,475
| Closed | -$142K | – | 3859 |
|
|
2018
Q2 | $142K | Buy |
1,475
+1,058
| +254% | +$102K | ﹤0.01% | 3323 |
|
|
2018
Q1 | $44K | Buy |
417
+194
| +87% | +$20.5K | ﹤0.01% | 3574 |
|
|
2017
Q4 | $35K | Buy |
223
+180
| +419% | +$28.3K | ﹤0.01% | 3632 |
|
|
2017
Q3 | $6K | Buy |
43
+38
| +760% | +$5.3K | ﹤0.01% | 4001 |
|
|
2017
Q2 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 4271 |
|